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Abstract 42 
 43 
 44 
Necrotic enteritis is an economically important disease of chickens caused by Clostridium 45 
perfringens. Immunity to necrotic enteritis is not fully characterized yet, but previous 46 
reports indicate that immunoprotective potential is present in the secreted component of 47 
C. perfringens. This study aimed to compare the vaccine potential of the supernatants of 48 
8 chicken strains of C. perfringens differing in origin, level of alpha toxin production and 49 
presence of netB gene. The supernatant of only one strain provided full protection, while 50 
one other strain provided partial protection against a severe infection challenge. Our 51 
results indicate that the protective characteristics of the supernatants are not solely based 52 
on the presence of NetB or alpha toxin. 53 
 54 
1. Introduction 55 
Clostridium perfringens is the causative agent of necrotic enteritis, an intestinal 56 
disease that affects industrial poultry worldwide [1, 2]. After the ban of growth promoting 57 
antibiotics in the European Union, necrotic enteritis has become much more widespread. 58 
It is mainly contained by using curative antibiotics or ionophore anticoccidials [3, 4]. The 59 
use of curative antibiotics and anticoccidials, however, holds the risk of inducing 60 
resistance among the C. perfringens population and the rest of the intestinal microbiota. 61 
 62 
Vaccination would be a valuable approach for the prevention of necrotic enteritis. C. 63 
perfringens strains are ubiquitous and notorious for the wide range of toxins and 64 
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virulence factors they excrete in their environment [5]. These different virulence factors 65 
and toxins may be considered as potential candidate antigens.  66 
Previously, results from our research group suggested the presence of host-specific 67 
virulence factors present in C. perfringens chicken strains isolated from necrotic enteritis 68 
outbreaks [6]. The majority of the chicken strains are toxinotype A, meaning that they 69 
carry the plc gene encoding alpha toxin [7-10]. For a long time, it was believed that this 70 
alpha toxin, a metalloenzyme with lecithinase and sphingomyelinase activities, was the 71 
major virulence factor involved in necrotic enteritis [11]. Recently, a novel pore forming 72 
toxin, NetB, was discovered [12]. Whereas a plc deletion mutant from a virulent C. 73 
perfringens chicken strain was still capable of inducing necrotic lesions in the gut of 74 
experimentally infected broilers, a netB deletion mutant from the same strain was not [12, 75 
13]. Although not involved in the onset of necrotic lesions, alpha toxin may still play a 76 
role in the pathogenesis of the disease. The critical importance of NetB for the 77 
development of necrotic enteritis is still under discussion as occasionally isolates that 78 
lack the netB gene can be found .in birds suffering from necrotic enteritis and necrotic 79 
enteritis has been reproduced with netB negative isolates.[2, 14-16]. Besides alpha toxin 80 
and NetB, C. perfringens secretes growth inhibiting factors and hydrolytic proteins, such 81 
as collagenases, that play or might play a role in the pathogenesis of necrotic enteritis [2, 82 
17, 18]. However, the role of these proteins in immunity to necrotic enteritis in chickens 83 
still needs to be elucidated. As the supernatant of C. perfringens contains a lot of 84 
potential immunoreactive compounds, the supernatant and its content has been studied as 85 
a potential vaccine to prevent clinical and subclinical necrotic enteritis with moderate 86 
degrees of success [19, 20]. Up till now, no full immunity to necrotic enteritis has been 87 
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achieved with supernatant-based vaccines. Moreover, it is not known whether chicken 88 
derived C. perfringens strains produce supernatants that differ in their capacity to induce 89 
a strongly protective immune response. 90 
 91 
The aim of this study was to compare the immunoprotective potential of the 92 
supernatants from 8 C. perfringens strains with different characteristics with regard to 93 
flock health status, NetB toxin and level of alpha toxin production.  94 
95 
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2. Materials and methods 96 
2.1 Strains   97 
Eight C. perfringens type A strains isolated from chickens and belonging to different 98 
genotypes, as analyzed by Pulsed Field Gel Electrophoresis (PFGE), were included [8]. 99 
All strains were used for supernatant production. All C. perfringens bacteria were grown 100 
anaerobically at 37°C in brain heart infusion (BHI) broth (Oxoid, Basingstoke, UK). C. 101 
perfringens strains 56 and 61 were used as challenge strains in an in vivo necrotic enteritis 102 
model described below and have been shown to be highly virulent in the applied in vivo 103 
model before [6, 21]. A summary of the characteristics of the strains is given in Table 1. 104 
 105 
2.2 Alpha toxin production and detection of the netB gene 106 
The alpha toxin production levels of the strains are shown in Table 1 and were 107 
determined in an earlier report [8].  108 
 109 
The presence of the netB gene was determined by PCR using the primers AKP78 (5′-110 
GCTGGTGCTGGAATAAATGC-3′) and AKP79 (5′-TCGCCATTGAGTAGTTTCCC-111 
3′), as described by Keyburn et al. [12]. Lactate dehydrogenase cytotoxicity assays were 112 
performed as an indicator for NetB expression [12]. Overnight cultures were grown in 113 
BHI. The supernatants were filter sterilized and dialyzed overnight against 10 mM Tris-114 
HCl pH 8.5. To test for cytotoxicity, the culture supernatants were added to the medium 115 
of chicken hepatoma (LMH) cells (ATCC CRL-2117) in a 1:4 dilution with cell medium. 116 
The cells were incubated for 3 hours at 37°C and 5% CO2. Lactate dehydrogenase release 117 
in the supernatant was used as an indicator of cytolysis and hence NetB production and 118 
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was measured using the Cytotoxicity Detection Kit (Roche Applied Sciences, Penzberg, 119 
Germany). As a positive control, 10% Triton X-100 (Sigma Aldrich, St. Louis MO, USA) 120 
was added to the cells. The negative control consisted of BHI 1:4 diluted with cell 121 
medium that was added to the cells. Percentage cytotoxicity was determined relative to 122 
the control groups. Experiments were repeated four times. For the LDH cytotoxicity 123 
assays, a one-way analysis of variance was used to detect significant differences in the 124 
relative cytotoxicity percentages of the supernatants (P<0.05) followed by a post-hoc 125 
Bonferroni test for multiple comparisons (P<0.0625). 126 
 127 
2.3 Vaccines 128 
In trials 1 and 2, the C. perfringens strains were grown in BHI supplemented with 129 
0.37% glucose for 14 hours at 37°C in an anaerobic (84 % N2, 8 % CO2 and 8 % H2) 130 
workstation (Ruskinn Technology, South Wales, UK). Supernatants derived from these 131 
overnight cultures were concentrated by dialysis against a 20 kDa polyethyleneglycol 132 
(PEG, Sigma Aldrich, St. Louis MO, USA) solution, followed by further concentration 133 
and desalting using Centricon columns (Millipore, Billerica, MA, USA). Protein 134 
concentrations from the supernatants were determined by the Bradford method with a 135 
commercially available Bradford reagens (Bio-Rad, Hercules, CA, USA). The 136 
concentrated supernatant samples were diluted in PBS to a final concentration of  137 
7 µg/200 µl or 70 µg/200 µl respectively.  138 
 139 
2.4 Experimental setup of the in vivo trials 140 
The in vivo necrotic enteritis challenge model was applied as described previously 141 
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[21]. Groups of 30 (trial 1) or 27 (trial 2 and 3) broilers were fed a wheat/rye-based 142 
(43%/7.5%) diet, with soybean meal as protein source.  143 
In trial 1, vaccination took place in 8 groups of birds with supernatants from 8 different 144 
strains (strains 7, 11, 23, 37, 43, 48, 56, 61). On day 3 and day 12 post-hatching, the birds 145 
were vaccinated subcutaneously in the neck with a 200 µl dose of supernatant containing 146 
7 µg and 70 µg total protein respectively. QuilA (Brenntag Biosector, Frederikssund, 147 
Denmark) was used as an adjuvant (50 µg/bird/vaccination). At the same time, one 148 
control group got placebo vaccinated with PBS and 50µg of QuilA/bird/vaccination. 149 
Another control group was left unvaccinated. In trial 2, only the supernatant of strain 23 150 
was used for vaccination in the same way as described for trial 1. The control group was 151 
vaccinated with PBS and QuilA. In trial 3, no prior vaccination took place. 152 
In all three trials, Nobilis Gumboro D78 vaccine (Schering-Plough Animal Health, 153 
Brussels, Belgium) was given in the drinking water on day 16 in all groups. From day 17 154 
onwards, the same diet was used with the exception that fishmeal (30%) replaced soy 155 
bean as protein source. On days 17, 18, 19 and 20, oral challenge was performed three 156 
times a day with approximately 4.108 cfu C. perfringens bacteria. On day 18, all birds 157 
were orally inoculated with a ten-fold dose of Paracox-5 (Schering-Plough Animal 158 
Health).In trial 1, oral challenge was performed with virulent strain 56 whereas in trial 2, 159 
the chickens were challenged with virulent strain 56 or 61. In trial 3, the virulence of 160 
strain 23 was compared to that of strain 56 in the necrotic enteritis challenge model. In 161 
trial 3, a negative control group was included consisting of birds to which only a 10-fold 162 
dose of Paracox-5 was administered.  163 
On days 22, 23 and 24, each time one third of the birds in each group were 164 
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euthanized and necropsied. Intestinal lesions in the small intestine (duodenum to ileum) 165 
were scored as described by Keyburn et al.[13]. Birds with lesion scores of 2 (1 to 5 166 
necrotic lesions) or more were classified as necrotic enteritis positive. The data were 167 
analyzed with SPSS Statistics 17.0 software (SPSS Inc., Chicago) using the binary 168 
logistic regression method to compare the number of necrotic enteritis positive animals 169 
within the test groups. Bonferroni’s correction for multiple comparisons was applied 170 
(P<0.05/n) for the first vaccination trial and significance was determined at P < 0.005. 171 
For all other trials, significance was determined at P<0.05.  172 
 173 
3. Results  174 
3.1 Detection of the netB gene and NetB cytotoxic effect towards LMH cells 175 
PCR showed that strains 7, 11, 43 and 48 were netB negative, whereas strains 23, 37, 176 
56 and 61 carry the netB gene. The in vitro cytopathic effect of all supernatants towards 177 
LMH cells was determined as an indicator for NetB activity [12, 15]. The relative 178 
cytotoxicity percentages of the supernatants from the different strains are shown in Table 179 
1. The post-hoc Bonferroni method for multiple comparison confirmed that the 180 
supernatants of all but one (strain 11) netB negative strains were significantly less 181 
cytotoxic towards LMH cells than the supernatants of netB positive isolates 23, 37, 56 182 
and 61 (P<0.00625). 183 
 184 
3.2 Vaccination experiments 185 
The vaccination experiment (trial 1) clearly showed that vaccination with the 186 
supernatant of netB negative strains 7, 11 and 43 did not result in immunoprotection 187 
 9 
(Table 2). Vaccination with supernatant of netB positive strains 37 and 56 did not result 188 
in immunoprotection either. Vaccination with supernatant from strains 23 and 48 resulted 189 
in a significant decrease in number of birds with necrotic lesions (P<0.005). Only 190 
vaccination with supernatant of strain 23, a netB positive strain and low alpha toxin 191 
producer, totally prevented the development of necrotic lesions after severe challenge. 192 
The supernatant of strain 48 (netB negative, high alpha toxin producer) provided partial 193 
protection. 194 
Since the toxins in the supernatants were not neutralized, a variable number of chicks 195 
died shortly after vaccination. High percentages of dead chicks were observed after 196 
vaccination with supernatant of strains 11 and 48 (high alpha toxin producers) and strain 197 
61 (low alpha toxin producer). 198 
In a second vaccination trial, none of the chickens that received subcutaneous 199 
vaccination with supernatant of strain 23 showed lesions, while 20% and 19% of the 200 
chickens vaccinated with adjuvant only were positive for necrotic lesions after challenge 201 
with virulent strain 56 and 61 respectively (Table 2).   202 
 203 
 204 
205 
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4. Discussion  206 
Only vaccination with two supernatants out of eight, i.e. those from strains 23 and 207 
48, significantly protected the birds against necrotic enteritis (trial 1). Vaccination with 208 
supernatant of strain 23 resulted in full protection against necrotic enteritis after 209 
challenge with two different virulent strains (trial 2). To our knowledge, this is the first 210 
time that vaccination with supernatant has such a profound effect. Previous reports on 211 
vaccination experiments with supernatants or toxoids show a significant reduction in the 212 
number of animals with necrotic lesions or partial protection but not total protection [19]. 213 
Vaccination of parent birds with type A or C toxoid decreased the occurrence of enteritis 214 
or hepatitis lesions with 5 to 15% in the progeny but did not totally prevent the 215 
development of necrotic enteritis [22]. 216 
 217 
When the immunoprotective potential of the eight supernatants is compared with the 218 
presence of the netB gene or level of presumed NetB-associated hepatocyte toxicity of 219 
the respective strains, it shows that the supernatants of 3 out of 4 netB negative strains 220 
confer no immunoprotective potential at all. Presence of a netB gene in combination with 221 
a cytopathic effect of the supernatants towards LMH cells was not associated with 222 
immunoprotective potential for the supernatants of strains 37, 56 and 61. All four netB 223 
positive strains, 23 37, 56 and 61, are characterised by high relative cytotoxicity 224 
percentages towards LMH cells of over 75%. For the Australian virulent necrotic 225 
enteritis strain EHE-NE18, it was confirmed that deletion of the netB gene resulted in 226 
loss of cytotoxicity [12]. In this study, two netB negative strains, 11 and 48, show 227 
medium relative cytotoxicity percentages towards LMH cells of 61% and 43% 228 
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respectively. These results indicate that for some strains, other proteins may be involved 229 
in the cytotoxicity towards LMH cells. Caution is thus recommended when correlating 230 
LDH cytotoxicity assays with levels of NetB expression.  231 
Since strain 23 produces low levels of alpha toxin in vitro whereas strain 48 produces 232 
high levels, the immunoprotective potential of the supernatans does not seem to depend 233 
on he amount of alpha toxin present. Remarkably, many chicks died shortly after 234 
vaccination with supernatants of the high alpha toxin producers strains 11 and 48, 235 
indicating that alpha toxin could play a role in the high rate of mortality often observed 236 
in severe cases of clinical necrotic enteritis. This shock effect has been described before 237 
[11, 19]. It has been shown that a plc mutant is still capable of inducing necrotic lesions 238 
[13]. This finding does not rule out that alpha toxin can play a secondary role in necrotic 239 
enteritis. When the intestinal epithelium is severely compromised, alpha toxin can reach 240 
the blood stream resulting in damage to organs or blood vessels. The supernatant of 241 
strain 61, a low alpha toxin producer, might be toxic to the chicks due to another 242 
unknown combination of toxic compounds. 243 
 244 
The results of this study show that the immunity to necrotic enteritis induced after 245 
immunization with supernatant of C. perfringens strains is not entirely determined by the 246 
concentration of alpha toxin or NetB but also involves other immunogens. These findings 247 
explain the varying degrees of partial protection observed after immunizations with 248 
vaccines based on a single antigenic protein such as alpha toxin, a hypothetical protein 249 
(presumably a metalloprotease) and pyruvate-ferredoxine oxidoreductase,.. where 250 
necrotic enteritis still developed in the flock after experimental challenge but the total 251 
 12 
number of birds with lesions was significantly reduced [19, 23]. Which unique antigenic 252 
features causes the supernatant of strain 23 to protect broilers against the development of 253 
necrotic enteritis even after severe challenge with different virulent strains is currently 254 
not known. 255 
 256 
In conclusion, our results indicate that the immunoprotective potential of the 257 
supernatants of C. perfringens necrotic enteritis strains is not solely determined by the 258 
strains’ level of alpha toxin expression or by the presence of the netB gene. The secreted 259 
component of strain 23 owes its immunoprotective features to a so far unknown 260 
combination of immunogenic compounds. 261 
 262 
263 
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TABLES 338 
Table 1. Characteristics of the strains and results of the lactate dehydrogenase 339 
cytotoxicity assay of LMH cells treated with ther1:4 diluted supernatants of these strains 340 
Strain 
 
Health status 
of the flock1 
Alpha toxin 
production2 
Detection 
of the netB 
gene 
Relative 
percentage 
cytotoxicity of the 
supernatant3 
Standard 
deviation 
7 healthy Low - 1 2 
11 healthy high - 61 10 
23 healthy Low + 75 15 
37 diseased moderate + 86 17 
43 diseased moderate - 13. 4 
48 diseased high - 43 18 
56 diseased moderate + 87. 12 
61 diseased Low + 89. 15 
1 Diseased means that there was a necrotic enteritis outbreak in the flock. 341 
2 As determined in [8].  342 
3Percentage cytotoxicity of the supernatants were determined relative to control wells 343 
treated with 10% Triton X-100 (positive control) or 1:4 diluted BHI (negative control). 344 
The values are averages of 4 independent trials. 345 
346 
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Table 2. Total number of birds with macroscopic necrotic enteritis lesions (lesion score 347 
≥2) in the vaccination experiments 348 
Trial Vaccination 
Group* 
Strain 
used for 
challenge 
Number of 
animals with 
lesions/total 
number 
Percentage of 
animal with 
lesions 
Number of dead 
chicks due to 
vaccination/total 
number§ 
1 SN 7 56 20/29 69 % 0/30 
 SN 11 56 8/13 61 % 16/30 
 SN 23 56 0/29a 0 % 0/30 
 SN 37 56 13/24 54 % 2/30 
 SN 43 56 23/30 76 % 0/30 
 SN 48 56 3/17a 17 % 13/30 
 SN 56 56 12/24 50 % 2/30 
 SN 61 56 4/12 33 % 18/30 
 PBS 56 12/25 47 % 0/30 
 no vaccination 56 15/26 56 % 0/30 
2 PBS 56 5/25 20 % 0/27 
 SN 23 56 0/25b 0 % 0/27 
 PBS 61 5/26 19 % 0/27 
 SN 23 61 0/25c 0 % 0/27 
*SN= supernatant 349 
§only chicks that died within 24 hours after vaccination are mentioned 350 
a values with superscripts differ significantly (P<0.005 for trial 1) from both the PBS-vaccinated 351 
as the non-vaccinated group (trial 1) 352 
b,c Values with superscripts differ significantly (P<0.05) from the control group vaccinated with 353 
PBS group and infected with the respective strain (trial 2) 354 
 355 
